GSK (GSK.L) Why Activism Might Be the Right Medicine.
GSK share price at the lower level of a 10-year trading range. An activist & an 23rd June briefing from the CEO on an asset spin-off and future...
301 Views
Eddingpharm: First Impressions
Eddingpharm plans to list on the HKEX. This Insight analyzes the company's products and pipeline. The main question is whether enthusiasm for the...
376 Views
Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC48
This article analyzed two core products from RemeGen: RC18 and RC 48. The commercialization of these two products would have direct impact on the...
405 Views
India ECM 2020 Mid-Year Review - A Year of Secondary and Rights Issues
Its been a quiet year for listings for most of Asia-Pacific with only Hong Kong being a more recent exception. To say that its been a quite year...
433 Views
SK Biopharm IPO Industry Analysis & Contract Details
In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...
224 Views